do the reagent for patients coming to the hospital. this is kind of a foreseeable event. we can do this. two years ago we had to ramp up telgs testing and we haven t ramped up nearly as much as we should. you look at other countries you get a pack of seven every week or every day if you need them. this was foreseeable. for us to try to fix this now when we re in a surge, is the wrong way to do this. this should have been fixed months ago, pushing to get more tests out, more tests approved and safe for people, but we should have had this a long time ago. yeah. hopefully it will change soon and they will become readily available especially in hospitals to aid health care workers such as yourself. dr. swaminathan, thanks so much for the time. thank you. just ahead, we ll be taking a look at the incredible life and legacy of archbishop desmond tutu who passed away at the age of 90.
SAN DIEGO, Dec. 2, 2021 /PRNewswire/ Werfen, a worldwide leader in specialized diagnostics for autoimmune disease, is pleased to announce the CE Mark of Aptiva CTD Essential Reagent for use
found in test samples from november 19th that were just sequenced. japan found its first omicron variant case. a man who traveled from namibia. its borders closed to all foreigners on tuesday. south african leaders are slamming those global travel banns as ineffective and punitive. we feel that the travel ban is very unfair. south african science should be commended for discovering this new variant and sharing the information with the world. we have played our role very responsibly. reporter: one disturbing impact of the travel restrictions is that scientists are telling me they re struggling even to get reagent into the country because of the flights being cut off. now that s a critical element that they need in the lab to try and test just how dangerous this variant is. david mckenzie reporting from johannesburg, south africa, thank you very much.